BrainPill review
Updated September 28, 2026 · AffCue Editorial Team · Facts checked September 26, 2026
We earn a commission when you sign up through links on this site. Partner status can affect where a brand appears in our rankings.
Our verdict
BrainPill pays Up to 60% per sale on a cps basis through SellHealth, and the health focus makes it a straightforward fit for publishers already covering supplements and wellness. The single payout model and global reach keep the offer list narrow, so check the deal terms before committing traffic.
Key facts
- Best for
- Publishers with health and supplement traffic who can sell on a completed sale.
- Commission terms
- Up to 60% per sale (Source, checked September 26, 2026)
- Networks
- SellHealth (Source, checked September 26, 2026)
- Commission (%)
- up to 60% (Source, checked September 26, 2026)
- Verticals
- Health (Source, checked September 26, 2026)
- Legal entity
- Leading Edge Health (Source, checked September 26, 2026)
- Pricing model
- CPS
- Region
- Global
- Official website
- brainpill.com
Pros and cons
Pros
- Commission of Up to 60% per sale sits above 50% per sale and above the revenue share terms published for VigRX Plus.
- Health is the only category listed under health, so the offer catalogue stays focused on one audience.
- Availability is global, so the programme can be promoted outside a single national market.
- Leading Edge Health is the named operator behind the programme.
Cons
- Commission is tied to a completed sale under the cps model, so unpaid referrals earn nothing.
- Cookie windows across the health programmes in the directory run 30 to 45 days, so plan campaigns on a short attribution window.
- Reach runs through SellHealth alone, which narrows the deal set compared with programmes running several networks.
Who it suits
- Sites whose readers already follow brain health, supplement and nootropics topics.
- Publishers comfortable promoting one health brand offer through SellHealth.
- Media buyers who can drive a completed sale rather than a sign-up.
Who should look elsewhere
- CashKaro, if cashback referrals suit you better, since it pays 10% of friend's cashback rather than a share of a product sale.
- TestRX, when a stated 50% per sale rate fits your product line better than a percentage of sale price.
- VigRX Plus, for publishers who prefer terms built on revenue share and a per-sale upsell figure over a percentage of the product sale.
Commission and cookie
BrainPill pays Up to 60% per sale, so the headline rate is a percentage of each completed sale rather than a flat bounty. The cps model means a referral pays nothing until the sale clears, which keeps tracking simple for publishers. Because the headline figure is a ceiling rather than a guarantee, check the offer terms for the products you plan to promote.
Frequently asked questions
How much does BrainPill pay per sale?+
BrainPill pays Up to 60% per sale to approved publishers. The rate is a percentage of the sale rather than a flat bounty, so a higher order value earns more. Payment is on a cps basis, so nothing is due until a referral's order completes.
How long is the cookie window?+
A cookie window figure is worth confirming directly with the programme before campaigns are planned. Across the health programmes AffCue covers, the median window is 30 days, with the longest at 45. Treat a longer window as something to check rather than assume.
Which network and operator run the programme?+
The programme runs through SellHealth, as listed in the terms, and the operator behind it is Leading Edge Health. Publishers work through that network rather than a separate direct agreement, and the health category narrows the catalogue to health products.
Which countries can I promote it in?+
The programme is listed as global, so publishers outside a single national market can apply. Region coverage does not change the Up to 60% per sale rate, so plan campaigns on the same commercial basis in every market you take on.
What payout threshold should I expect?+
Payout thresholds are set through the network rather than by the brand, so confirm the figure in your account. Across the programmes in the directory, the median minimum payout is €43.85, with the lowest at €0 and the highest at €500.
Is the commission recurring?+
Recurring commission is not listed for BrainPill: the cps model pays once on a completed sale. Most programmes in the directory are also non-recurring at 55.5%, so publishers relying on subscription renewals should look elsewhere.
Who is the programme suited to?+
It suits publishers whose readers follow brain health, supplement and wellness content, since health is the only category listed. It suits less well anyone chasing a lead bounty, a recurring payout or a multi-network deal, as the cps model pays on completed sales alone.
How does the rate compare with similar health offers?+
The listed rate of Up to 60% per sale is above 50% per sale and above the revenue share terms published for VigRX Plus. CashKaro runs a different structure, 10% of friend's cashback, which is tied to a friend's cashback rather than a product sale.
Sources
- brainpill.com checked September 26, 2026
Backs: Verticals
“Your New Secret Weapon For Peak Mental Performance”
- brainpill.com/faq checked September 26, 2026
Backs: Legal entity
“Brain Pill is a quality product from Leading Edge Health, a Canadian company”
- sellhealth.com checked September 26, 2026
Backs: Commission (%), Commission terms, Pricing model, Networks, Region
“Earn Up To A 60% Commission On Every Sale”
Compiled from 3 source pages, checked September 26, 2026. We did not open an account.
Not confirmed yet: Cookie window, Recurring commission.
BrainPill
Publishers with health and supplement traffic who can sell on a completed sale.